Paladin Labs Inc.: Canadian Women To Be Granted Easier Access To Emergency Contraception
Apr 17th 2008Drug InformationWomen's Health / OBGYN
Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that the National Drug Scheduling Advisory Committee (NDSAC) has recommended Paladin’s application to move Plan BŪ from Behind-the-Counter status to full Over-the-Counter (OTC) status to the National Association of Pharmacy Regulatory Authorities (NAPRA).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
